IDH1 and glioma: In addition to the eleven proteins selected following our GSEA analysis, conventional glioma pathology markers IDH-1, ATRX, and p53, and five other candidate markers—based on published experimental evidence on the mechanisms by which glioma cells can influence neural function in their vicinity—were selected.